This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most major subdisciplines of radiation oncology, including sarcomas, pediatrics and lymphomas, and the role of radiotherapy in the multidisciplinary management of cancer patients. The course reviews key evidence that forms the basis for current clinical practice guidelines and trends in new approaches. In addition, the course covers treatment of oligometastases and use of SBRT to improve outcomes for patients with metastatic disease. It also provides hands-on experience in contouring for breast, lymphomas and upper GI malignancies. It also informs on the use of protons and heavy ions in the clinic and the use of radiation in the treatment of benign disease.
Target Audience
The meeting is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, radiation therapists, radiation dosimetrists, nurses and all other health professionals involved in the field of radiation oncology.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
Describe and implement the latest radiation therapy treatment recommendations for clinical scenarios commonly encountered in clinical practice.
Safely utilize the latest radiation technologies to improve patient care.
Describe the data and clinical use of protons and heavy ions in the management of patients.
Appropriately and safely incorporate the treatment of oligometastases into clinical practice.
Describe the management of benign diseases with radiation.
+ Topics:
Head and Neck
Gynecologic: Endometrial and Cervical
Physics: Protons and Heavy Ions
Gastrointestinal: Upper and Lower
eContouring for Upper GI
Central Nervous System
Lung
Radiobiology of Benign Disease
Breast
eContouring for Breast
Genitourinary
Oligometastatic Cancers and SBRT
Sarcomas
Lymphomas
eContouring for Lymphomas
Pediatrics
Reviews
There are no reviews yet.